vs
Side-by-side financial comparison of Incyte (INCY) and PLEXUS CORP (PLXS). Click either name above to swap in a different company.
Incyte is the larger business by last-quarter revenue ($1.3B vs $1.2B, roughly 1.1× PLEXUS CORP). Incyte runs the higher net margin — 23.8% vs 4.3%, a 19.6% gap on every dollar of revenue. On growth, Incyte posted the faster year-over-year revenue change (20.9% vs 18.7%). Over the past eight quarters, Incyte's revenue compounded faster (10.4% CAGR vs 7.2%).
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Plex Systems, Inc. is an American software company based in Troy, Michigan. The company develops and markets the Plex Manufacturing Cloud, a software as a service (SaaS) or cloud computing ERP for manufacturing.
INCY vs PLXS — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.2B |
| Net Profit | $303.3M | $49.8M |
| Gross Margin | — | 10.2% |
| Operating Margin | 23.7% | 5.3% |
| Net Margin | 23.8% | 4.3% |
| Revenue YoY | 20.9% | 18.7% |
| Net Profit YoY | 91.7% | 27.5% |
| EPS (diluted) | $1.47 | $1.82 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | $1.1B | ||
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.0B | — |
| Q1 26 | $303.3M | $41.2M | ||
| Q4 25 | $299.3M | — | ||
| Q3 25 | $424.2M | — | ||
| Q2 25 | $405.0M | — | ||
| Q1 25 | $158.2M | — | ||
| Q4 24 | $201.2M | — | ||
| Q3 24 | $106.5M | — | ||
| Q2 24 | $-444.6M | — |
| Q1 26 | — | 9.9% | ||
| Q4 25 | 92.0% | — | ||
| Q3 25 | 92.8% | — | ||
| Q2 25 | 93.5% | — | ||
| Q1 25 | 93.0% | — | ||
| Q4 24 | 92.5% | — | ||
| Q3 24 | 92.4% | — | ||
| Q2 24 | 92.7% | — |
| Q1 26 | 23.7% | 5.1% | ||
| Q4 25 | 22.3% | — | ||
| Q3 25 | 32.5% | — | ||
| Q2 25 | 43.6% | — | ||
| Q1 25 | 19.5% | — | ||
| Q4 24 | 25.6% | — | ||
| Q3 24 | 12.8% | — | ||
| Q2 24 | -45.8% | — |
| Q1 26 | 23.8% | 3.8% | ||
| Q4 25 | 19.9% | — | ||
| Q3 25 | 31.1% | — | ||
| Q2 25 | 33.3% | — | ||
| Q1 25 | 15.0% | — | ||
| Q4 24 | 17.1% | — | ||
| Q3 24 | 9.4% | — | ||
| Q2 24 | -42.6% | — |
| Q1 26 | $1.47 | $1.51 | ||
| Q4 25 | $1.46 | — | ||
| Q3 25 | $2.11 | — | ||
| Q2 25 | $2.04 | — | ||
| Q1 25 | $0.80 | — | ||
| Q4 24 | $0.90 | — | ||
| Q3 24 | $0.54 | — | ||
| Q2 24 | $-2.04 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $303.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $5.6B | $1.5B |
| Total Assets | $7.3B | $3.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $248.8M | ||
| Q4 25 | $3.1B | — | ||
| Q3 25 | $2.5B | — | ||
| Q2 25 | $2.0B | — | ||
| Q1 25 | $1.9B | — | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $987.3M | — |
| Q1 26 | $5.6B | $1.5B | ||
| Q4 25 | $5.2B | — | ||
| Q3 25 | $4.7B | — | ||
| Q2 25 | $4.2B | — | ||
| Q1 25 | $3.7B | — | ||
| Q4 24 | $3.4B | — | ||
| Q3 24 | $3.2B | — | ||
| Q2 24 | $3.0B | — |
| Q1 26 | $7.3B | $3.2B | ||
| Q4 25 | $7.0B | — | ||
| Q3 25 | $6.3B | — | ||
| Q2 25 | $5.8B | — | ||
| Q1 25 | $5.7B | — | ||
| Q4 24 | $5.4B | — | ||
| Q3 24 | $5.0B | — | ||
| Q2 24 | $4.7B | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
INCY
Segment breakdown not available.
PLXS
| Asia-Pacific | $652.0M | 56% |
| Americas | $397.0M | 34% |
| Europe, Middle East and Africa | $116.0M | 10% |
